{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:44:15Z","timestamp":1790286255272,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018929","name":"German Network for Bioinformatics Infrastructure","doi-asserted-by":"publisher","award":["FKZ 031 A 534A"],"award-info":[{"award-number":["FKZ 031 A 534A"]}],"id":[{"id":"10.13039\/501100018929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.ajpath.2018.11.018","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T03:07:42Z","timestamp":1549940862000},"page":"619-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0662-3394","authenticated-orcid":false,"given":"Kathrin E.","family":"Witzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Gro\u00dferueschkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"J\u00fctte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Horn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Roghmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"von Landenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-6614","authenticated-orcid":false,"given":"Thilo","family":"Bracht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Kallenbach-Thieltges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5150-4979","authenticated-orcid":false,"given":"Heiko","family":"K\u00e4fferlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Schork","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Eisenacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Noldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tannapfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Sitek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gerwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2018.11.018_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","article-title":"Bladder cancer incidence and mortality: a global overview and recent trends","volume":"71","author":"Antoni","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib2","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib3","first-page":"1","article-title":"Biomarkers for bladder cancer management: present and future","volume":"2","author":"Ye","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.urology.2005.07.062","article-title":"Bladder cancer: epidemiology, staging and grading, and diagnosis","volume":"66","author":"Kirkali","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2018.11.018_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/107327480000700402","article-title":"Contemporary management of superficial bladder cancer","volume":"7","author":"Pow-Sang","year":"2000","journal-title":"Cancer Control"},{"key":"10.1016\/j.ajpath.2018.11.018_bib8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1078-1439(99)00020-4","article-title":"Updated concepts and treatment of carcinoma in situ","volume":"4","author":"Lamm","year":"1998","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib9","doi-asserted-by":"crossref","first-page":"x23","DOI":"10.1093\/annonc\/mdl231","article-title":"Muscle invasive and metastatic bladder cancer","volume":"17 Suppl 10","author":"Sternberg","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib10","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.eururo.2013.11.046","article-title":"EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines","volume":"65","author":"Witjes","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-7-42","article-title":"Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring","volume":"7","author":"Rizzardi","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.urology.2005.10.028","article-title":"Review pathology in a diagnostic bladder cancer trial: effect of patient risk category","volume":"67","author":"Witjes","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2018.11.018_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jprot.2013.04.024","article-title":"Identification of potential bladder cancer markers in urine by abundant-protein depletion coupled with quantitative proteomics","volume":"85","author":"Chen","year":"2013","journal-title":"J Proteomics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.clgc.2012.06.003","article-title":"Discovery of potential bladder cancer biomarkers by comparative urine proteomics and analysis","volume":"11","author":"Lei","year":"2013","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2014.05.012","article-title":"Low- and high-grade bladder cancer appraisal via serum-based proteomics approach","volume":"436","author":"Bansal","year":"2014","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ajpath.2018.11.018_bib16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.eururo.2009.02.031","article-title":"Serum proteomic profiling in patients with bladder cancer","volume":"56","author":"Schwamborn","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/1078-0432.CCR-08-1143","article-title":"Cystatin B as a tissue and urinary biomarker of bladder cancer recurrence and disease progression","volume":"15","author":"Feldman","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2018.11.018_bib18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1159\/000020364","article-title":"p53 Immunohistochemistry as a prognostic marker in bladder cancer: playground for urology scientists?","volume":"38","author":"Schmitz-Dr\u00e4ger","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0140-6736(98)05383-5","article-title":"Expression of cytokeratin 20 redefines urothelial papillomas of the bladder","volume":"353","author":"Harnden","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2018.11.018_bib20","first-page":"400","article-title":"Differential diagnosis of urothelial carcinoma in situ from non-neoplastic urothelia: analysis of CK20, CD44, P53 and Ki67","volume":"30","author":"Asgari","year":"2016","journal-title":"Med J Islam Repub Iran"},{"key":"10.1016\/j.ajpath.2018.11.018_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1074\/mcp.M115.054585","article-title":"Immunohistochemical markers distinguishing cholangiocellular carcinoma (CCC) from pancreatic ductal adenocarcinoma (PDAC) discovered by proteomic analysis of microdissected cells","volume":"15","author":"Padden","year":"2016","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.oraloncology.2015.08.008","article-title":"Quantitative proteomic analysis of microdissected oral epithelium for cancer biomarker discovery","volume":"51","author":"Xiao","year":"2015","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib23","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1021\/pr4005794","article-title":"Quantitative proteomic analysis of microdissected breast cancer tissues: comparison of label-free and SILAC-based quantification with shotgun, directed, and targeted MS approaches","volume":"12","author":"Liu","year":"2013","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpath.2018.11.018_bib24","doi-asserted-by":"crossref","first-page":"37226","DOI":"10.18632\/oncotarget.9362","article-title":"Proteomic analysis of stromal proteins in different stages of colorectal cancer establishes tenascin-C as a stromal biomarker for colorectal cancer metastasis","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2018.11.018_bib25","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1074\/mcp.M115.051524","article-title":"Comparative tissue proteomics of microdissected specimens reveals novel candidate biomarkers of bladder cancer","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib26","doi-asserted-by":"crossref","first-page":"44829","DOI":"10.1038\/srep44829","article-title":"Spatial and molecular resolution of diffuse malignant mesothelioma heterogeneity by integrating label-free FTIR imaging, laser capture microdissection and proteomics","volume":"7","author":"Gro\u00dferueschkamp","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2018.11.018_bib27","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1366\/12-06801","article-title":"Infrared spectroscopic imaging: the next generation","volume":"66","author":"Bhargava","year":"2012","journal-title":"Appl Spectrosc"},{"key":"10.1016\/j.ajpath.2018.11.018_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/jbio.201200126","article-title":"FTIR microspectroscopy of selected rare diverse sub-variants of carcinoma of the urinary bladder","volume":"6","author":"Hughes","year":"2013","journal-title":"J Biophoton"},{"key":"10.1016\/j.ajpath.2018.11.018_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/jbio.201300131","article-title":"Molecular pathology via IR and Raman spectral imaging","volume":"6","author":"Diem","year":"2013","journal-title":"J Biophoton"},{"key":"10.1016\/j.ajpath.2018.11.018_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1039\/C5CS00846H","article-title":"Fundamental developments in infrared spectroscopic imaging for biomedical applications","volume":"45","author":"Pilling","year":"2016","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.ajpath.2018.11.018_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jbio.200810024","article-title":"Disease recognition by infrared and Raman spectroscopy","volume":"2","author":"Krafft","year":"2009","journal-title":"J Biophoton"},{"key":"10.1016\/j.ajpath.2018.11.018_bib32","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1039\/C4AN01978D","article-title":"Marker-free automated histopathological annotation of lung tumour subtypes by FTIR imaging","volume":"140","author":"Gro\u00dferueschkamp","year":"2015","journal-title":"Analyst"},{"key":"10.1016\/j.ajpath.2018.11.018_bib33","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.bbamem.2006.04.010","article-title":"Chemical imaging of biological tissue with synchrotron infrared light","volume":"1758","author":"Miller","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2018.11.018_bib34","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1118\/1.2890391","article-title":"Fourier transform infrared imaging and small angle x-ray scattering as a combined biomolecular approach to diagnosis of breast cancer","volume":"35","author":"Ooi","year":"2008","journal-title":"Med Phys"},{"key":"10.1016\/j.ajpath.2018.11.018_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/jbio.201200132","article-title":"Immunohistochemistry, histopathology and infrared spectral histopathology of colon cancer tissue sections","volume":"6","author":"Kallenbach-Thieltges","year":"2013","journal-title":"J Biophoton"},{"key":"10.1016\/j.ajpath.2018.11.018_bib36","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1039\/b904808a","article-title":"Resonant Mie scattering in infrared spectroscopy of biological materials: understanding the \u201cdispersion artefact\u201d","volume":"134","author":"Bassan","year":"2009","journal-title":"Analyst"},{"key":"10.1016\/j.ajpath.2018.11.018_bib37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1039\/B921056C","article-title":"Resonant Mie Scattering (RMieS) correction of infrared spectra from highly scattering biological samples","volume":"135","author":"Bassan","year":"2010","journal-title":"Analyst"},{"key":"10.1016\/j.ajpath.2018.11.018_bib38","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1021\/ac60214a047","article-title":"Smoothing and differentiation of data by simplified least squares procedures","volume":"36","author":"Savitzky","year":"1964","journal-title":"Anal Chem"},{"key":"10.1016\/j.ajpath.2018.11.018_bib39","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1021\/acs.jproteome.5b00053","article-title":"Analysis of disease-associated protein expression using quantitative proteomics\u2014fibulin-5 is expressed in association with hepatic fibrosis","volume":"14","author":"Bracht","year":"2015","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ajpath.2018.11.018_bib40","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1074\/mcp.M113.028027","article-title":"Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study","volume":"12","author":"Megger","year":"2013","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/nimg.2000.0546","article-title":"A common language network for comprehension and production: a contribution to the definition of language epicenters with PET","volume":"11","author":"Papathanassiou","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.ajpath.2018.11.018_bib42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib43","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jprot.2015.06.015","article-title":"ProCon: PROteomics CONversion tool","volume":"129","author":"Mayer","year":"2015","journal-title":"J Proteomics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib44","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/1097-0215(20000720)89:4<350::AID-IJC6>3.0.CO;2-3","article-title":"Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma","volume":"89","author":"Tannapfel","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib45","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe"},{"key":"10.1016\/j.ajpath.2018.11.018_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1471-2105-12-77","article-title":"pROC: an open-source package for R and S+ to analyze and compare ROC curves","volume":"12","author":"Robin","year":"2011","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs, part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.ju.0000055471.78783.ae","article-title":"Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder","volume":"169","author":"Bol","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib49","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/1097-0142(20010401)91:7<1284::AID-CNCR1130>3.0.CO;2-E","article-title":"Impact of second opinion pathology in the definitive management of patients with bladder carcinoma","volume":"91","author":"Coblentz","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.juro.2009.11.049","article-title":"The role of pathology review of transurethral bladder tumor resection specimens in the modern era","volume":"183","author":"Lee","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib51","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1046\/j.1464-410x.2000.00356.x","article-title":"Clinical significance of interobserver differences in the staging and grading of superficial bladder cancer","volume":"85","author":"Tosoni","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.ajpath.2018.11.018_bib52","first-page":"261","article-title":"Overdiagnosis of bladder carcinoma","volume":"30","author":"Cheng","year":"2008","journal-title":"Anal Quant Cytol Histol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib53","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.juro.2014.01.087","article-title":"The importance of transurethral resection of bladder tumor in the management of nonmuscle invasive bladder cancer: a systematic review of novel technologies","volume":"191","author":"Richards","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib54","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/ijc.24112","article-title":"a candidate progression marker of human transitional cell carcinoma of the bladder, is differentially regulated by PPAR in urothelial cancer cells","volume":"124","author":"Boiteux","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib55","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1289\/ehp.10279","article-title":"Transformation of human urothelial cells (UROtsa) by as and cd induces the expression of keratin 6a","volume":"116","author":"Somji","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ajpath.2018.11.018_bib56","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.0308619101","article-title":"The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells","volume":"101","author":"Komuro","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2018.11.018_bib57","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.7150\/thno.18198","article-title":"AHNAK2 is a novel prognostic marker and oncogenic protein for clear cell renal cell carcinoma","volume":"7","author":"Wang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.ajpath.2018.11.018_bib58","doi-asserted-by":"crossref","first-page":"31775","DOI":"10.18632\/oncotarget.15990","article-title":"AHNAK2 is a potential prognostic biomarker in patients with PDAC","volume":"8","author":"Lu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ajpath.2018.11.018_bib59","first-page":"99","article-title":"Urothelial bladder cancer urinary biomarkers","volume":"25","author":"Noon","year":"2014","journal-title":"EJIFCC"},{"key":"10.1016\/j.ajpath.2018.11.018_bib60","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1158\/1078-0432.CCR-09-3373","article-title":"Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma","volume":"16","author":"Mengual","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2018.11.018_bib61","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2469::AID-CNCR24>3.0.CO;2-U","article-title":"Survival of patients with carcinoma in situ of the urinary bladder","volume":"85","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2018.11.018_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/iju.12232","article-title":"Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy","volume":"21","author":"Roghmann","year":"2014","journal-title":"Int J Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","article-title":"Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","volume":"55","author":"Shabsigh","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s101470200042","article-title":"Complications of bacillus Calmette-Guerin therapy in superficial urothelial cancer: clinical analysis and implications","volume":"7","author":"Suzuki","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib65","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0022-5347(17)37316-0","article-title":"Incidence and treatment of complications of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer","volume":"147","author":"Lamm","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib66","first-page":"340","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: review of complications and their treatment","volume":"68","author":"Paterson","year":"1998","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ajpath.2018.11.018_bib67","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0090-4295(98)00219-2","article-title":"Sensitivity and specificity of NMP-22, telomerase, and BTA in the detection of human bladder cancer","volume":"52","author":"Landman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2018.11.018_bib68","first-page":"472","article-title":"Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer","volume":"45","author":"Thomas","year":"1999","journal-title":"Clin Chem"},{"key":"10.1016\/j.ajpath.2018.11.018_bib69","first-page":"2511","article-title":"Complement factor H or a related protein is a marker for transitional cell cancer of the bladder","volume":"4","author":"Kinders","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2018.11.018_bib70","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0090-4295(97)00508-6","article-title":"Clinical evaluation of the BTA trak assay and comparison to voided urine cytology and the bard BTA test in patients with recurrent bladder tumors","volume":"50","author":"Ellis","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.ajpath.2018.11.018_bib71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.urolonc.2007.06.002","article-title":"UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with urinary cytology testing","volume":"26","author":"Hajdinjak","year":"2008","journal-title":"Urol Oncol"},{"key":"10.1016\/j.ajpath.2018.11.018_bib72","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cncy.21287","article-title":"uCyt+\/ImmunoCyt and cytology in the detection of urothelial carcinoma. An update on 7422 analyses","volume":"121","author":"Comploj","year":"2013","journal-title":"Cancer Cytopathol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018307399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944018307399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:05:45Z","timestamp":1762081545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944018307399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0002944018307399"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.11.018","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrated Fourier Transform Infrared Imaging and Proteomics for Identification of a Candidate Histochemical Biomarker in Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2018.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}